Contact

Click here for a confidential contact or call:

1-212-350-2764

International Competition Issues

Return to:

Page 3 of 35

The Antitrust Week In Review

Posted  04/13/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

Generic drugmakers win EU okay to cooperate in coronavirus fight.  Generic drugmakers will be allowed to cooperate to supply hospital medicines for COVID-19 patients without fear of breaching the bloc’s competition rules, EU antitrust regulators said on Wednesday. The step is the latest loosening of the...

The Antitrust Week In Review

Posted  03/30/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

U.S. antitrust agencies pledge quick action for anti-COVID-19 efforts.  The two U.S. federal antitrust enforcers said on Tuesday that they would move quickly to approve collaborations that businesses, including hospital systems, put together to address rapidly growing public health concerns raised by the...

The Antitrust Week In Review

Posted  03/23/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

EU regulators ask companies to delay merger filings over coronavirus disruption.  European Union regulators have asked companies seeking to complete their desired mergers to delay submitting antitrust filings due to the coronavirus outbreak.  That could affect the timelines of agreed deals. Among the...

The Antitrust Week In Review

Posted  03/17/20
Here are some of the developments in antitrust news this past week that we found interesting and are following. France Fines Apple $1.2 Billion for Antitrust Issues.  France’s antitrust regulator on Monday fined Apple 1.1 billion euros, or $1.2 billion, putting more pressure on the company as it grapples with the coronavirus outbreak that has threatened its supply chains and closed its retail stores. France’s...

The Antitrust Week In Review

Posted  03/9/20
Here are some of the developments in antitrust news this past week that we found interesting and are following. Novartis unit Sandoz agrees to pay $195 million to resolve antitrust charges.  Novartis’ generic drugs unit Sandoz has agreed to pay $195 million to reach a deferred prosecution agreement aimed at resolving antitrust charges, the Justice Department said. The company was charged with rigging bids and...

The Antitrust Week In Review

Posted  03/2/20
United Technologies, Raytheon offer EU concessions over $120 billion merger deal.  United Technologies Corp. and Raytheon Co. (RTN.N) have offered concessions to address EU antitrust concerns about their plan to create a $120 billion U.S. aerospace and defense giant, a filing on the European Commission website showed on Monday. The companies submitted their concessions on Friday. The European Commission, which did...

The Antitrust Week In Review

Posted  02/24/20
Here are some of the developments in antitrust news this past week that we found interesting and are following. Trump Administration Sees No Threat to Economy From Monopolies.  President Trump and his economic team see “no need to hastily rewrite the federal government’s antitrust rules,” drawing a battle line with leading Democratic presidential candidates on an issue that has increasingly drawn the...

The Antitrust Week In Review

Posted  02/17/20

Here are some of the developments in antitrust news this past week that we found interesting and are following.

FTC antitrust victory on Qualcomm questioned by appeals court.  The U.S. government’s antitrust victory over chip supplier Qualcomm Inc. drew tough questions for the Federal Trade Commission from a panel of three appellate judges in San Francisco on Thursday. The U.S. 9th Circuit Court of Appeals heard...

The Antitrust Week In Review

Posted  02/10/20
Here are some of the developments in antitrust news this past week that we found interesting and are following. Administration Ends Antitrust Probe of 4 Automakers, Calif.  The Trump administration has ended its antitrust probe into a deal between California and four of the world's biggest automakers, after failing to find that the companies' conduct violated the law. The Justice Department's investigation, which...

The Antitrust Week In Review

Posted  02/3/20
Here are some of the developments in antitrust news this past week that we found interesting and are following. Martin Shkreli Faces New Accusations Over High-Priced Drug.  Martin Shkreli, a former pharmaceutical executive serving a seven-year prison sentence for defrauding investors, was accused on Monday of trying to maintain a monopoly over the lifesaving drug Daraprim through anticompetitive tactics. The...
1 2 3 4 5 35

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: